Trademark: 97151041
Word
C-SRRNA
Status
Registered
Status Code
700
Status Date
Tuesday, December 12, 2023
Serial Number
97151041
Registration Number
7243728
Registration Date
Tuesday, December 12, 2023
Mark Type
4000
Filing Date
Wednesday, December 1, 2021
Published for Opposition
Tuesday, May 9, 2023

Trademark Owner History
Elixirgen Therapeutics, Inc. - Original Registrant

Classifications
5 Dosage medium preparations, namely, pharmaceutical preparations for the treatment and prevention of infectious diseases, cancer, and aging-related diseases; vaccines; regenerative medicine, namely, pharmaceuticals for cell rejuvenation

Trademark Events
Dec 12, 2023
Notice Of Registration Confirmation Emailed
Dec 12, 2023
Registered-Principal Register
Nov 7, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Nov 4, 2023
Allowed Principal Register - Sou Accepted
Aug 23, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 22, 2023
Statement Of Use Processing Complete
Aug 15, 2023
Use Amendment Filed
Aug 22, 2023
Sou Extension 1 Granted
Aug 15, 2023
Sou Extension 1 Filed
Aug 22, 2023
Case Assigned To Intent To Use Paralegal
Aug 15, 2023
Sou Teas Extension Received
Aug 15, 2023
Teas Statement Of Use Received
Jul 4, 2023
Noa E-Mailed - Sou Required From Applicant
May 9, 2023
Official Gazette Publication Confirmation E-Mailed
May 9, 2023
Published For Opposition
Apr 19, 2023
Notification Of Notice Of Publication E-Mailed
Apr 4, 2023
Approved For Pub - Principal Register
Jan 19, 2023
Teas/Email Correspondence Entered
Jan 19, 2023
Correspondence Received In Law Office
Jan 19, 2023
Teas Response To Office Action Received
Sep 19, 2022
Notification Of Non-Final Action E-Mailed
Sep 19, 2022
Non-Final Action E-Mailed
Sep 19, 2022
Non-Final Action Written
Sep 10, 2022
Assigned To Examiner
Dec 6, 2021
New Application Office Supplied Data Entered
Dec 4, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24